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Relationship between Blood Pressure of Spontaneously Hypertensive Rats and Alterations in Membrane Properties of Mesenteric Arteries
JIANN-WU WEI, RONALD A. JANIS, AND EDWIN E. DANIEL SUMMARY Spontaneously hypertensive rats (SHR) and two strains of normotensive rats were compared with respect to enzymatic activities and calcium accumulation of plasma membrane and endoplasmic reticulum enriched fractions from their mesenteric arteries. Increased specific activities of alkaline phosphatase, 5-nucleotidase and Mg 2+ -ATPase, and increased ATP-dependent calcium accumulation were found in 5-to 6-month-old SHR as compared to both strains of age-matched normotensive rats.
Alkaline phosphatase was increased in 33-day-old "early hypertensive" and 3-to 4-month-old SHR, but 5'-nucleotidase, Mg 2+ -ATPase, and calcium accumulation were not . Hydralazine treatment of young SHR partially prevented the increase of both alkaline phosphatase activity and blood pressure that develops with age. The relationship between alkaline phosphatase activity and the alterations in vascular reactivity associated with hypertension remains to be determined.
WE FOUND that the specific activities of certain enzymes of a plasma membrane enriched fraction isolated from mesenteric arteries 1 of spontaneously hypertensive rats (SHR) were greater than those of Ontario normotensive Wistar rats (NWRo). 2 Furthermore, maximum ATP-dependent calcium accumulation under certain conditions was greater for this fraction from SHR than that from NWRo. 2 There is no ideal control for SHR and therefore more than one strain of normotensive rat should be used in studies of this type. In the present investigation we have studied enzymatic and calcium accumulation parameters in a second strain, California Wistar normotensive rats (NWRc). Levy 3 has reported that this strain exhibits a vascular response to pressor agents that is identical to that of the Kyoto normotensive rats from which the SHR was developed. Therefore, one aim of this study was to evaluate whether the differences previously reported 2 between 5-to 6-month-old SHR and NWRo were due to strain differences unrelated to hypertension. Two other types of experiments also were carried out in the present investigation to further characterize the relationship between hypertension and the alterations in the abovementioned membrane parameters. First, three age groups of SHR and NWRc were compared to determine whether enzymatic activities or calcium accumulation were abnormal in the early as well as in the late stages of hypertension. Second, these same parameters were studied in mesenteric arteries from rats treated with the antihypertensive agent, hydralazine, to determine whether the prevention of hypertension would also prevent the development of differences between SHR and normotensive rats.
Methods

ANIMALS
The hypertensive rats 4 were obtained in the 23rd generation from Dr. David Triggle, State University of New York at Buffalo, who had obtained them in the 19th generation from the National Institutes of Health (NIH). From the 19th to the 23rd generations, it is our understanding that they were not bred strictly through brothersister matings, but all matings were within the small group of rats obtained from NIH and their offspring. From the 23rd to th 30th generations, the rats were bred by brothersister matings. The male rats used in our studies were from the 25th to 30th generations. Age-matched male NWRc were supplied by Simonsen Laboratories, Gilroy, California, and NWRo by Woodlyn Farm, Ontario. Hydralazine treatment of SHR and NWRc was started at less than 1 month of age. The rats were fed, ad libitum, 80 mg of hydralazine/liter of drinking water during the 1st month, and then 100 mg/liter during the next 2-3 months. The systolic blood pressure was monitored by using a Narco Bio-Systems model PE-300 sphygmomanometer for indirect measurement of tail artery pressure as previously described. 2
SUBCELLULAR FRACTIONS
The rats were killed by a blow on the head and mesenteric arteries were quickly removed and freed from fat, connective tissue, and veins. Plasma membrane and endoplasmic reticulum fractions from NWR and SHR were isolated by the use of a discontinuous sucrose density gradient as previously described. 2 It should be noted that the designation of the endoplasmic reticulum fraction as such is tentative because there is no established marker for this fraction from smooth muscle; 2 for this reason also, the amount of endoplasmic reticulum contaminating the plasma membrane fraction is not known. This contamination appears to be small in view of the purification of plasma membrane markers achieved. Also, it seems not to affect Ca uptake properties of the plasma membrane fraction which differ in several respects from those of endoplasmic reticulum fraction, as shown here and previously. 1 -2
ENZYME ASSAYS AND CALCIUM ACCUMULATION* STUDIES
Protein, 5 phosphate, 6 5'-nucIeotidase, Mg 2+ -ATPase, and alkaline phosphatase were measured as described previously. 1 ' 2 Calcium accumulation in the presence of ATP was carried out in a reaction mixture containing 100 mM KC1, 5 mM MgCl 2 , 5 mM ATP (disodium salt), 0.1 mM CaCl 2 labeled with 0.4 /xCi 45 CaCl 2 , 15-25 ng membrane protein, 40 mM imidazole buffer at pH 7.0 in a total volume of 1 ml which yields a 17 /XM free calcium concentration. The free calcium concentration was determined as described elsewhere. 2 Millipore filtration technique was used to determine 45 Ca accumulation. 1
REAGENTS AND DRUGS
Hydralazine HCI was supplied by Sigma. The divalent cation ionophore, X-537 A (supplied by Hoffman-La-Roche) was dissolved in 95% ethanol, and 10 /xl of the drug were added to a total of 1 ml of reaction mixture. The other reagents and drugs were dissolved in 40 mM imidazole buffer at pH 7.0. Solutions were prepared from distilled deionized water and analytical grade reagents. Organic compounds were the highest purity available from Sigma; 45 CaCI 2 was obtained from Amersham/Searle.
STATISTICAL TEST
Values were compared by the Student's r-test. Differences with P value <0.05 were considered significant. Standard errors of the means are bracketed in the figures.
Results
COMPARISON OF THE TWO STRAINS OF NORMOTENSIVE RATS
There were no significant differences between the 5-to 6-month-old NWRo and NWRc strains of rat in the parameters measured. This was true for both body weight and blood pressure as well as for measurements made on the subcellular fractions: 5'-nucleotidase, Mg 2+ -ATPase, alkaline phosphatase, and calcium accumulation (Table  1) . Therefore, the quantitative and qualitative differences 17.2 ± 0.9 10.9 ± 0.5 * "Calcium accumulation" is used as an operational term for all the processes involved in association of calcium with vesicles whether by binding or by transport across the vesicle membrane; however, we prefer the term "calcium uptake," which we have used in the same sense elsewhere. 12 NWRo and NWRc = Ontario and California normotensive Wistar rats, respectively; PM and ER = plasma membrane and endoplasmic reticulum enriched fractions, respectively. Results are given as mean ± SEM.
Specific activities are expressed as /imoles phosphate released mg"' protein hr" 1 , for 5'-nucleotidase and for Mg !+ -ATPase; as jtmoles pnitrophenol released mg" 1 protein hr" 1 for alkaline phosphatase; and aŝ moles calcium accumulated g"' protein in 10 min for calcium accumulation.
Mesenteric arteries from 6-12 rats of each group were used for each experiment; n (number of experiments) = 4-5. For the first two parameters, 30-40 rats from each group were measured. * The results for NWRo were published previously in Table 3 of Wei et l» in the above parameters between NWRc and SHR at this age were similar to the differences between NWRo and SHR that were described previously. 2
COMPARISON OF HYPERTENSIVE AND NORMOTENSIVE RATS AT DIFFERENT AGES
The mean body weight of SHR was the same as that of NWRc at 33 days of age, but was significantly less than that of NWRc at both 3-4 months and 5-6 months of age. In contrast, the mean blood pressure of SHR was significantly greater than that of NWRc even at an age of 33 days ( Table 2 ). In general, the specific activities of 5'-nucleotidase and Mg 2+ -ATPase in the plasma membrane fraction of arteries from NWRc decreased significantly with age, especially between ages 3-4 months and 5-6 months ( Table 3 ). However, the activities of these enzymes did not change in SHR over this total period; there was a small, temporary reduction in activities at 3-4 months. No significant decreases in enzyme activities of the endoplasmic reticulum fractions occurred with age in NWRc, but in SHR, Mg 2+ -ATPase activity was increased at 5-6 months (Table 4 ). Therefore, the specific activities of both 5'nucleotidase and Mg 2+ -ATPase were significantly greater in the plasma membrane fraction, but only the latter Values ( m e a n ± SEM) a r e expressed as in Table 1 ; abbreviations as in Table 2 ; n = 4 . * Significant differences from values at 3 3 days. t Significantly different from normotensive. Table 2 .
* Values significantly different from those obtained under the same conditions for the corresponding fraction of NWR arteries. enzyme was greater in the endoplasmic reticulum fraction of 5-to 6-month-old SHR when compared with NWRc.
In contrast to the decrease of 5'-nucleotidase and Mg 2+ -ATPase of the plasma membrane fraction with age in NWRc but not in SHR, alkaline phosphatase and calcium accumulating capacity in this fraction increased with age in SHR more than in NWRc (Table 3 ). However, alkaline phosphatase and calcium accumulation of the endoplasmic reticulum fraction from both strains of rat increased with age ( Table 4 ). Alkaline phosphatase activity initially was higher in both fractions from SHR compared to NWRc and the difference increased with age. Hence, the time course of the development of increased alkaline phosphatase activity in the two fractions was similar to that of increased blood pressure in SHR over the range studied. On the other hand, calcium-accumulating capacity, as measured under our experimental conditions, was not significantly greater for the plasma membrane fraction of SHR relative to NWRc until after hypertension had existed for several months ( Table 3 ).
The decrease in calcium accumulation in the presence of the divalent cation ionophore, X-537 A, for both fractions from 5-to 6-month-old SHR arteries was significantly greater than that of fractions from NWR arteries. This difference was not present at 1 month (Table 5 ) or at 3-4 months of age ( Table 6 ). The residual calcium accumula 1 tion by subcellular fractions of arteries in the presence of ATP and X-537 A was not different at different ages from NWRc or SHR (Tables 5 and 6 ).
EFFECT OF HYDRALAZINE TREATMENT
Treatment with hydralazine for approximately 3 months did not affect body weight of either strain of rat, but it did decrease blood pressures of both SHR and NWRc; this decrease was more marked for the hypertensive rats (Fig.  1) . The blood pressure of hydralazine-treated SHR was slightly but significantly higher than that of age-matched untreated NWRc (Fig. 1) .
The specific activity of alkaline phosphatase (Fig. 2) in the subcellular fractions of 3-to 4-month-old SHR was significantly greater than that of NWRc. Treatment with hydralazine partially prevented the increase in the specific activity of alkaline phosphatase which occurred between 33 days and 3-4 months in both fractions from SHR ( Fig.  2 and Tables 3 and 4 ). The specific activity of alkaline phosphatase in the plasma membrane fraction from NWRc arteries also increased slightly with age ( Table 3) . After hydralazine treatment, this enzyme activity in the plasma membrane fraction from NWRc arteries at 3-4 months old decreased to a level not significantly different from that at 33 days ( Fig. 2 and Table 3 ). The specific activity of alkaline phosphatase in the plasma membrane and endoplasmic reticulum fractions of hydralazinetreated SHR did not differ from that of untreated NWRc (Fig. 2) . Similarly, the specific activity of Mg 2+ -ATPase and 5'-nucleotidase (Table 7) in the subcellular fractions from 3-to 4-month-old rats did not differ significantly among the four groups (Table 7) ; this was expected because none of these activities had changed in 3-to 4month-old rats with hypertension compared to the values at 33 days (Tables 3 and 4 ). No significant increase in calcium accumulation was found in the plasma membrane or endoplasmic reticulum fractions of arteries from untreated 3-to 4-month-old SHR as compared to that of untreated NWRc (Tables 2 and 3 ). Hydralazine treatment of NWRc and SHR also did not result in a significant change in calcium accumulation by the subcellular fractions in either group (Table 6 ). ATP-dependent calcium accumulation by the subcellular fractions from both NWRc or SHR arteries was decreased similarly by the presence of X-537 A ( Values (mean ± SEM) are expressed as in Table 1 ; abbreviations as in Table 6 ;n = 4.
TABLE 6 Effect of X-537 A on Calcium Accumulation by Subcellular Fractions front Hydralazine-Treated Normotensive Wistar Rats (NWRt) and Spontaneously Hypertensive Rats (SHRt) and Untreated 3-to 4-Month-Old Rats
untreated NWRc and SHR as compared to similar fractions from hydralazine-treated animals ( Table 6 ).
Discussion
The significant increases in the specific activities of enzymes and in the capacity of active calcium accumulation of subcellular fractions of arteries from 5-to 6-month-old SHR as compared to those from NWRc confirm out previous report in which a different strain of control rat was used. 2 Both calcium accumulation and enzyme activities were the same in these two strains of normotensive rats (Table 1 ). This suggests that the differences observed between SHR and the normotensive rats may be related to hypertension rather than to differences in the rat strains. Further evidence relating these differences to hypertension may be provided by future studies of these blood vessels in Kyoto Wistar normotensive rats and by such studies in other forms of hypertension in which controls of the same genetic constitution can be used; such studies are in progress. Furthermore, there were only slight changes in these parameters, with the exception of alkaline phosphatase, in 33-day-old and 3-to 4-month-old SHR when compared to NWRc of the same age. The 33-day-old SHR were early hypertensive, because their blood pressures were significantly elevated compared to NWRc, whereas 3-to 4-month-old SHR were clearly hypertensive. Therefore, the appearance of these changes, except for that in alkaline phosphatase, followed the appearance of hypertension and may be a consequence of it. Since 5'-nucleotidase and Mg 2+ -ATPase were also increased in rats made hypertensive by salt treatment, 7 ' 8 these changes may result from hypertension, regardless of its etiology. The time course of elevation of alkaline phosphatase activity with age differed from the time course of change in other enzymes and calcium accumulation. The activities of other enzymes failed to decrease with age in SHR as they did in NWRc, whereas alkaline phosphatase activities were already increased in SHR compared to NWRc at 33 days, and continued to increase with age. The accumulation of calcium also increased with age in SHR but did not change in NWRc; however, this increase became significant only at 5-6 months. VOL. 40, No. 3, MARCH 1977 The activity of alkaline phosphatase was 3-5 times greater in the plasma membrane fraction than in the endoplasmic reticulum fraction; for 5'-nucleotidase, this difference was 6-7 times. This suggests that alkaline phosphatase may be a component of endoplasmic reticulum and not exclusively present as a contaminant. Whether the increase in this enzyme activity associated with hypertension is confined to the plasma membrane or occurs also in endoplasmic reticulum cannot be conclusively determined until a definite marker for endoplasmic reticulum is available.
The studies on hydralazine-treated NWRc and SHR were designed to resolve further the relationship between hypertension and these alterations. The mean systolic blood pressures of all untreated rats of the hypertensive strain 3-4 months of age was over 150 mm Hg. However, at that age the specific activities of 5'-nucleotidase, Mg 2+ -ATPase, and the amount of calcium accumulation (and ionophore-decreased calcium accumulation) in the subcellular fractions from SHR arteries were not significantly greater than those of NWRc. Only the specific activity of alkaline phosphatase in the plasma membrane and endoplasmic reticulum fractions of SHR arteries was significantly greater than that of NWR. Treatment with hydralazine decreased the blood pressures of SHR and NWRc, and the former was decreased much more than the latter. Similar results have been reported by another group. 9 Such treatment did not significantly change the specific activities of 5'-nucleotidase and Mg 2+ -ATPase, or the capacity for calcium accumulation by the subcellular fractions from either SHR or NWR arteries as compared to untreated rats. Also, there was no change relative to value for the 33-day-old rats. This suggests that the treatment had no permanent nonspecific effect on the enzymatic activities or calcium accumulation parameters studied. However, the treatment did prevent the increase in the specific activity of alkaline phosphatase in the subcellular fractions of hypertensive rat arteries. This was correlated with the prevention of the increase in blood pressure in both groups.
From this study it is clear that an increase in the specific activity of alkaline phosphatase of membranes from small blood vessels is closely associated with the increase in blood pressure, and may be related to the cause of hypertension. However, all other changes that we have observed in membranes from hypertensive blood vessels do appear to be secondary to increased blood pressure. The changes in alkaline phosphatase activity are not unique; other enzyme activities or other biochemical parameters may show a similar relationship to hypertension. For example, abnormalities in patterns of acid phosphatase isozymes are reported in SHR liver after 7 days of age but not in the fetal liver. 10 Histochemical studies on rat arteries have demonstrated that the AMPases (5'-nucleotidase) activity is increased in the earliest stage of renal and salt hypertension. 7 ' 8 On the other hand, Ichijima" found the activity of this enzyme unchanged in 1-month-old SHR, but increased in 4-to 6month-old, or older, SHR. The alterations observed in hypertensive rats were compared to the results of agematched normotensive ones. The reason for such a differ-ence is not known, but this difference may be related to a difference in pathogenesis between renal or salt hypertension and SHR. Our results confirm those of Ichijima's on SHR.
Ooshima 12 has reported a positive correlation between blood pressure and alkaline phosphatase activity in homogenates of the vascular system of SHR as compared to values for normotensive rats of similar ages. The blood pressure increase which occurs with age was diminished in hydralazine-treated SHR, and the parallel increase in alkaline phosphatase activity was similarly prevented. Therefore, our results further extend Ooshima's observation. In addition, a significant increase in the specific activity of alkaline phosphatase was found in the youngest SHR that we studied.
Little is known about the physiological function of alkaline phosphatase.' 3 However, it would be of considerable interest to know whether the phosphatase that we studied in SHR membranes has phosphoprotein phosphatase activity. There is increasing evidence that phosphoproteins may play a key role in regulating Ca 2+ transport and ATPase activity as well as membrane permeability, 1415 and it is known that some alkaline phosphatases have phosphoprotein phosphatase activity. 16 Furthermore, Sirica and co-workers 17 have considered the possiblity that decreased Mg 2+ -ATPase and 5'-nucleotidase, and increased alkaline phosphatase activities of regenerating liver plasma membrane, may be associated with specific membrane transport abnormalities.
Early alterations in vascular permeability of SHR have been reported. 1819 Of particular interest is a report by Shibata and co-workers 20 demonstrating that increased responsiveness to strontium, lanthanum, and manganese is present in the vascular smooth muscle of SHR before the onset of hypertension. In addition, Hansen and Bohr 21 have shown that the increased responsiveness of femoral arteries from hypertensive SHR to strontium and lanthanum is not caused by hypertension via increased wall stress nor is it caused by increased wall thickness. They also found that high concentrations of calcium do not depress the response of the femoral artery from SHR, unlike that from normotensive rats. A somewhat analogous response has been reported for aortic smooth muscle from SHR. 22 Lais and Brody 23 found that perfused hindquarters of SHR were supersensitive (defined as decreased ED 50 or threshold dose) to norepinephrine but not to barium or angiotensin, and concluded that SHR hypersensitivity is specific. In contrast, the studies cited above as well as those of Haeusler and Finch 24 on perfused mesenteric artery from SHR indicate that there is somewhat nonspecific supersensitivity in at least some part of the vasculature of SHR. It is this type of reactivity change that might be caused by a derangement of calcium metabolism. In our previous study 2 we found that in the presence of 1 mM calcium maximum ATP-independent calcium accumulation by the plasma membrane fraction from SHR arteries was significantly lower than that of NWR arteries. Furthermore, Hansen and Bohr 21 have suggested that a decreased number of calcium-binding sites in the plasma membrane of SHR may cause the increased excitability associated with the hypertension of SHR. Therefore, in the light of their results, it will be of great interest to determine whether the previously reported alteration in passive calcium accumulation 2 is present in early hypertensive SHR.
Clearly, the present investigation does not exclude the possibility that a primary change in calcium regulation is responsible for the altered sensitivity to contractile agents observed in the SHR mesenteric artery. 24 It may be that a derangement in calcium regulation exists but is not detected by the techniques employed. In addition to alterations in passive accumulation, there may be changes in the rate of calcium accumulation or release by membranes of SHR; this was not studied in the present investigation but further studies will determine whether such changes occur and whether they can be correlated with alterations in phosphatase metabolism and with the time course of the development of hypertension. Finally, it should be noted that qualitative differences in alterations of Ca 2+ uptake between membranes from small arteries and from aorta of SHR have been found and previously discussed. 225 
